Halmos on the AE Profiles of Dato-DXd and Other ADCs in NSCLC

Season 10, Episode 49,   Aug 05, 2024, 07:40 PM

Headliner
Share
Subscribe

Dr Halmos discusses common AEs associated with the ADCs that are used in NSCLC and ways to manage and mitigate these toxicities.

Share
Subscribe
Next
Park and Grivas Expand on Treatment Updates in Bladder Cancer
Top episodes
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air
Wise Summarizes Survival Data From ARASENS and PEACE-1 in Prostate Cancer
by OncLive® On Air